0001646343-18-000004.txt : 20180515 0001646343-18-000004.hdr.sgml : 20180515 20180515161742 ACCESSION NUMBER: 0001646343-18-000004 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180515 DATE AS OF CHANGE: 20180515 EFFECTIVENESS DATE: 20180515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEXTHERA CAPITAL LP CENTRAL INDEX KEY: 0001646343 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-17280 FILM NUMBER: 18836743 BUSINESS ADDRESS: STREET 1: 900 THIRD AVENUE STREET 2: SUITE 1100 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 213-7033 MAIL ADDRESS: STREET 1: 900 THIRD AVENUE STREET 2: SUITE 1100 CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001646343 XXXXXXXX 03-31-2018 03-31-2018 NEXTHERA CAPITAL LP
900 THIRD AVENUE SUITE 1100 NEW YORK NY 10022
13F HOLDINGS REPORT 028-17280 N
Daniel Malek Managing Member of the General Partner 6462137030 Daniel Malek New York NY 05-15-2018 0 40 607263 false
INFORMATION TABLE 2 nexthera13f_q12018.xml Abeona Therapeutics Inc COM 00289Y107 5302 369500 SH SOLE 369500 0 0 Adverum Biotechnologies Inc COM 00773U108 2907 501183 SH SOLE 501183 0 0 Allergan PLC SHS G0177J108 41840 248620 SH SOLE 248620 0 0 Akorn Inc COM 009728106 9439 504503 SH SOLE 504503 0 0 Arrowhead Pharmaceuticals Inc COM 04280A100 8033 1114097 SH SOLE 1114097 0 0 AstraZeneca PLC SPONSORED ADR 046353108 16925 484000 SH SOLE 484000 0 0 BioMarin Pharmaceutical Inc COM 09061G101 21016 259235 SH SOLE 259235 0 0 BioMarin Pharmaceutical Inc COM 09061G101 8731 107700 SH Call SOLE 107700 0 0 Bristol-Myers Squibb Co COM 110122108 21657 342399 SH SOLE 342399 0 0 Cara Therapeutics Inc COM 140755109 4346 351050 SH SOLE 351050 0 0 Cymabay Therapeutics Inc COM 23257D103 11076 852686 SH SOLE 852686 0 0 Catalyst Biosciences Inc COM NEW 14888D208 13896 538624 SH SOLE 538624 0 0 Cellectis SA SPONSORED ADS 15117K103 10485 332754 SH SOLE 332754 0 0 Clovis Oncology Inc COM 189464100 12809 242600 SH Call SOLE 242600 0 0 Corcept Therapeutics Inc COM 218352102 17193 1045196 SH SOLE 1045196 0 0 Dova Pharmaceuticals Inc COM 25985T102 15411 568243 SH SOLE 568243 0 0 FibroGen Inc COM 31572Q808 6971 150888 SH SOLE 150888 0 0 Homology Medicines Inc COM 438083107 243 13000 SH SOLE 13000 0 0 Global Blood Therapeutics Inc COM 37890U108 15222 315147 SH SOLE 315147 0 0 Heron Therapeutics Inc COM 427746102 11288 409000 SH SOLE 409000 0 0 Immunomedics Inc COM 452907108 15799 1081410 SH SOLE 1081410 0 0 Insmed Inc COM PAR $.01 457669307 20685 918523 SH SOLE 918523 0 0 Kura Oncology Inc COM 50127T109 6599 351955 SH SOLE 351955 0 0 Madrigal Pharmaceuticals Inc COM 558868105 4231 36226 SH SOLE 36226 0 0 Menlo Therapeutics Inc COM 586858102 2786 74142 SH SOLE 74142 0 0 Mylan NV SHS EURO N59465109 10745 261000 SH SOLE 261000 0 0 NewLink Genetics Corp COM 651511107 3625 500000 SH Call SOLE 500000 0 0 OncoSec Medical Inc COM NEW 68234L207 3881 2064297 SH SOLE 2064297 0 0 Pacira Pharmaceuticals Inc/DE COM 695127100 14909 478620 SH SOLE 478620 0 0 Perrigo Co PLC SHS G97822103 4646 55748 SH SOLE 55748 0 0 Sage Therapeutics Inc COM 78667J108 12600 78227 SH SOLE 78227 0 0 Seattle Genetics Inc COM 812578102 18998 362974 SH SOLE 362974 0 0 Sangamo Therapeutics Inc COM 800677106 14941 786376 SH SOLE 786376 0 0 Shire PLC SPONSORED ADR 82481R106 20846 139543 SH SOLE 139543 0 0 Sol-Gel Technologies Ltd SHS M8694L103 5334 517873 SH SOLE 517873 0 0 Stemline Therapeutics Inc COM 85858C107 8011 523624 SH SOLE 523624 0 0 SPDR S&P Biotech ETF S&P BIOTECH 78464A870 175460 2000000 SH Put SOLE 1000000 0 0 Xenon Pharmaceuticals Inc COM 98420N105 1857 379071 SH SOLE 379071 0 0 Zafgen Inc COM 98885E103 2992 401558 SH SOLE 401558 0 0 Zosano Pharma Corp COM NEW 98979H202 3528 700000 SH SOLE 700000 0 0